Ligand Pharmaceuticals Inc.

LGNDNASDAQ • USD
297.95 USD
↘ 3.76 (1.24%)🟢PRE MARKET (AS OF 03:45 AM EST)
🟢Market: OPEN

Shares of Ligand Pharmaceuticals Inc. (LGND) are trading at $297.95. The stock presents a bearish profile across the board: technical indicators signal "Sell" and our fundamental models agree with a "Sell" rating. Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 1/9 and a bullish Golden Cross on the moving averages. Furthermore, LGND is currently richly valued, trading at a premium to sector peers across key valuation metrics.

Technical & fundamental data as of Nov 16, 2026.

Open?N/A
High?N/A
Low?N/A
Prev. Close?$301.71
Volume?0
Avg. Volume?218.9K
Bid / Ask
Bid?$260.61 × 40
Ask?$345.06 × 40
Spread?$84.45
Midpoint?$302.84
Valuation & Ratios
Market Cap?6.0B
Shares Out?20.0M
Float?18.8M
Float %?94.2%
P/E Ratio?117.27
P/B Ratio?6.28
EPS?$2.57
Dividend?0.00%
Ex-Dividend?N/A
RelatedANIPADMA
News
Profile
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
Employees
47
Market Cap
6.2B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
1994-11-25
Address
3911 SORRENTO VALLEY BLVD
SAN DIEGO, CA 92121
Phone: 858-550-7500
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
6
Z-Score?
82
Momentum?
11
Short Sent.?
48
Piotroski F-Score?1/9Weak
Altman Z-Score?3.39Safe
Confidence?57%Low
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?13.12%High
Short Interest?2.5M
Days to Cover?10.5
Free Float18.8M
Avg Daily Volume234.1K
Settlement Date2026-10-30
Financial Health
Current Ratio?1.22Adequate
Quick Ratio?1.19Adequate
Cash Ratio?0.11Low
Debt/Equity?1.17Moderate
ValuationRICHLY VALUEDvs 2 peers + S&P 500
Score
39/100
P/E?
Peers
33
S&P
3
117.3PRICEY▾
P/B?
Peers
67
S&P
29
6.28FAIR▾
P/S?
Peers
33
S&P
3
23.78HIGH▾
P/FCF?
Peers
33
S&P
6
66.6PRICEY▾
EV/EBITDA?
Peers
33
S&P
3
109.0HIGH▾
EV/Sales?
Peers
33
S&P
3
28.00HIGH▾
Returns & Efficiency
ROE?
Peers
33
S&P
20
5.4%FAIR▾
ROA?
Peers
33
S&P
22
2.3%WEAK▾
Cash Flow & Enterprise
FCF?$90.6M
Enterprise Value?$7.1B
Fundamentals ratios updated end of day